| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4866828
Max Phase: Preclinical
Molecular Formula: C26H37BrN2O2
Molecular Weight: 409.59
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCCCCCCn1c2c([n+](CCCCCC)c1C)C(=O)c1ccccc1C2=O.[Br-]
Standard InChI: InChI=1S/C26H37N2O2.BrH/c1-4-6-8-10-11-15-19-28-20(3)27(18-14-9-7-5-2)23-24(28)26(30)22-17-13-12-16-21(22)25(23)29;/h12-13,16-17H,4-11,14-15,18-19H2,1-3H3;1H/q+1;/p-1
Standard InChI Key: YAFIVARLGOHKGO-UHFFFAOYSA-M
Associated Targets(non-human)
Mycobacterium tuberculosis variant bovis BCG 1626 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 409.59 | Molecular Weight (Monoisotopic): 409.2850 | AlogP: 5.80 | #Rotatable Bonds: 12 |
| Polar Surface Area: 42.95 | Molecular Species: | HBA: 3 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.27 | CX LogD: 2.27 |
| Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.28 | Np Likeness Score: -0.03 |
References
| 1. Fridianto KT, Li M, Hards K, Negatu DA, Cook GM, Dick T, Lam Y, Go ML.. (2021) Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosis., 64 (21.0): [PMID:34706190] [10.1021/acs.jmedchem.1c01383] |
Source
Source(1):